Trust Company’s ResMed RMD Stock Holding History

Trust Company’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$390	Hold	2	–	–	﹤0.01%	810
2026 Q1	$449	Hold	2	–	–	﹤0.01%	743
2025 Q4	$482	Buy	+2	New	+$511	﹤0.01%	705

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Trust Company's RMD Position: Q2 2026 in Review

Trust Company held its ResMed (RMD) position steady in Q2 2026 at 2 shares worth $390. The position accounts for ﹤0.01% of the portfolio, ranked #810.

Trust Company first reported a position in RMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $482 in Q4 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

Trust Company held 2 shares of ResMed worth $390 as of Q2 2026.
Trust Company left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of Trust Company's portfolio in Q2 2026, its #810 holding.
Trust Company first reported a position in ResMed in Q4 2025 and has held it in 3 quarters since.
Trust Company's ResMed position peaked at $482 in Q4 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.